Advertisement
Document › Details
Protagen AG. (3/15/11). "Press Release: Instraction and Protagen Form Strategic Alliance". Dortmund.
![]() |
Region | Germany |
![]() |
Organisation | Protagen AG |
| Group | Protagen (Group) | |
| Organisation 2 | Instraction GmbH | |
![]() |
Product | instrAction® Phase |
| Product 2 | protein purification (technology) | |
![]() |
Index term | Instraction–Protagen: protein separation, 201103– collab developm customised instAction Phases for downstream processing of biotherapeutics |
![]() |
Person | Schwarz, Thomas (Instraction GmbH 201103 Managing Director) |
instrAction GmbH, Ludwigshafen, the specialist for design and production of selective separation matrices and Protagen AG, Dortmund, a GMP certified service laboratory for protein analysis signed a strategic alliance for the development of customized instrAction® Phases for downstream processing of biotherapeutics.
"The instrAction® Phases are proprietary synthetic chromatography phases which show excellent performance compared to commonly used matrices for e.g. antibody purification. The unique know-how and expertise of Protagen in GMP-compliant protein analysis and related services will be decisive for the development of a portfolio of new tailor made separation phases for the production of recombinant protein drugs, other biotherapeutics and biosimilars", comments Dr. Thomas Schwarz, CEO of instrAction.
"In order to exploit the full value of this exciting new protein purification technology and to convince customers from pharma process development and production, it is important to provide convincing data sets from feasibility studies. Protagen has all the tools and know-how to support instrAction on its way to become the leading company in protein separation technology", underscores Dr. Stefan Müllner, CEO of Protagen.
About Protagen AG - www.protagen.de
Protagen AG is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.
About instrAction GmbH - www.instraction.com
instrAction, founded in 1997 and located at the BASF site in Ludwigshafen, develops and manufactures "instrAction® phases" as novel highly selective resins for chromatography. The proprietary technology enables the immobilization of a wide variety of functional ligands on a polymer network, coated on very different porous backbone materials. Small molecules as well as substances with high molecular weight are separated by highly selective reversible interactions. The high selectivity of an instrAction stationary phase is thereby reached by multivalent-multimodal interactions between target molecule and the functional ligands of the phase, similar to the lock-and-key principle.
Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: info@protagen.de
Media Enquiries
Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: bettina.franz@protagen.de
Record changed: 2011-12-29 |
More documents for Protagen (Group)
- [1] Hölle & Hüttner AG. (12/7/11). "Pressemitteilung: Innovative Neugeborenen-Diagnostik. Bundesregierung unterstützt Hölle & Hüttner mit 244.385 €"....
- [2] Protagen AG. (10/28/11). "Press Release: Protagen and Charles River Form Strategic Partnership"....
- [3] Protagen AG. (10/10/11). "E-News: Protagen AG Appoints Dr. Jörg Müller as Head of Marketing"....
- [4] CEMIT – Center of Exellence in Medicine and IT GmbH (Oncotyrol). (8/21/11). "Pressemitteilung: Prostatakrebs an Antikörpern im Blut erkennen. Innsbrucker und Dortmunder Wissenschaftlerinnen publizieren in Fachzeitschrift »Prostate« – Oncotyrol macht Fort...
- [5] Protagen AG. (8/2/11). "Press Release: SuppreMol Employs Protagen Biomarkers in SLE Study". Munich & Dortmund....
- [6] Protagen AG. (7/13/11). "Press Release: Protagen and Vela Form Strategic Partnership"....
- [7] Scienion AG. (4/19/11). "Press Release: Protagen Counts on Scienion Technology". Dortmund & Berlin....
- [8] Protagen AG. (3/29/11). "Press Release: Protagen to Apply UNIarray Platform for Biogen Idec". Dortmund....
- [9] Protagen AG. (11/2/10). "Press Release: Protagen at the European Antibody Congress 2010". Dortmund....
- [10] MicroDiscovery GmbH. (10/13/10). "Press Release: Protagen AG and MicroDiscovery GmbH Cooperate in Biomarker Development". Berlin & Dortmund....
To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com
» top
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg)










![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)